Atlas Trials

TDF Dose Adjustment VS. Switching to TAF in TDF-experienced CHB Patients With Renal Impairment

Clinical trial NCT04391608 · UNKNOWN

Trial details

NCT number
NCT04391608
Sponsor
Mahidol University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Renal InsufficiencyTenofovir
Start date
2019-11-09
Primary completion
2022-07-31
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.